Here are 4 takeaways from the C.D.C. approving vaccines for children under 5.
The New York Times -

Scientific advisers to the Centers for Disease Control and Prevention unanimously decided the benefits outweigh the risks for children under 5 despite some reservations about thin data on efficacy, and the agency’s director signed off on the shots.

Related Articles

Latest in Usa

More from The New York Times | Coronavirus COVID-19 Pandemic,Vaccines Immunization,Omicron variant,Babies